Ruth Arnon

Ruth Arnon is a prominent Israeli biochemist who has made significant contributions to the field of chemistry. Her work has had a profound impact on the development of innovative treatments for various diseases. Notably, she is credited as the co-developer of Copaxone, a groundbreaking drug used to treat multiple sclerosis. This achievement showcases her expertise and dedication to advancing medical research.

As the Paul Ehrlich Professor of Immunology at the Weizmann Institute of Science, Arnon continues to push the boundaries of scientific knowledge. Her current research focuses on the development of anti-cancer and influenza vaccinations, underscoring her commitment to improving human health. Through her work, Arnon has established herself as a leading figure in the scientific community, and her contributions are likely to have a lasting impact on the field of biochemistry and beyond.